Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
See Latest ArticlesPneumococcal conjugated vaccine: PHiD-CV
Expert Review of Anti-infective Therapy, 11/10/09
Dinleyici EC et al. – It has been proved that PHiD–CV is immunogenic, safe and well–tolerated in children. This vaccine can be coadministered with routinely used pediatric vaccines. PHiD–CV is also immunogenic for ten serotypes as assessed by post–primary and post–booster dose opsonophagocytic activity responses. Optimal scheduling, safety and immunogenicity data in children with different risk factors for IPD, or whether it will provide herd immunity, are the questions waiting for answers in the postmarketing period.
Today in Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
HIV-Specific Health Care Utilization and Mortality among Tuberculosis/HIV Coinfected Persons
AIDS Patient Care and STDs, 10/06/09
Influenza Management Guide 2009-2010
American Family Physician, 11/18/09
Bed bugs - What the GP needs to know
Australian Family Physician, 11/09/09
Sponsor
Article Search
Sponsor
Sponsor